Metabolism of AZO Dyes: Implication for Detoxication and Activation

References

• Combes R. D., Haveland-Smith R. B. A review of the genotoxicity of food, drug and cosmetic colours and other azo, triphenylmethane and xanthene dyes. Mutat. Res. 1982; 98: 101–248
   PubMed Web of Science ®Google Scholar
• Corke C. T., Bunce N. J., Beaumont A., Merrick R. L. Diazo-nium cations as intermediates in the microbial transformation of chloroanilines to chlorinated biphenyls, azo compounds, and triazenes. J. Agric. Food Chem. 1979; 27: 644–646
   Web of Science ®Google Scholar
• Clarke E. A. Evaluation of the molecular design approach to the development of new dyes. Drug Metab. Rev. 1984; 15: 997–1009
   PubMed Web of Science ®Google Scholar
• Garner R. C., Martin C. N., Clayson D. B. Carcinogenic aromatic amines and related compounds. Chemical Carcinogens, C. E. Searle. American Chemical Society, Washington, DC 1984; vol. 1: 175
   Google Scholar
• IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man: Some Aromatic Azo Compounds. 1975; vol. 8
   Google Scholar
• Martin C. N., Kennelly J. C. Metabolism, mutagenicity, and DNA binding of biphenyl-based azodyes. Drug Metab. Rev. 1985; 16: 89–117
   PubMed Web of Science ®Google Scholar
• Venkataraman K. The Chemistry of Synthetic Dyes. Academic Press, New York 1952; vol. 1, chap. 11
   Google Scholar
• Stead C. V. Azo dyes. The Chemistry of Synthetic Dyes, K. Venkataraman. Academic Press, New York 1970; vol. 3, chap. 6
   Google Scholar
• Pentimalli L. Researches on the aromatic azocompounds. The oxidation of the 4-dimethylamino-azobenzene. Tetrahedron 1959; 5: 27–37
   Web of Science ®Google Scholar
• Daniel J. W. The excretion and metabolism of edible food colors. Toxicol. Appl. Pharmacol. 1962; 4: 572–594
   PubMed Web of Science ®Google Scholar
• Scheline R. R., Longberg B. The absorption, metabolism and excretion of the sulphonated azo dye, acid yellow, by rats. Acta Pharmacol. Toxicol. 1965; 23: 1–14
   Google Scholar
• Ryan A. J., Wright S. E. The excretion of some azo dyes in rat bile. J. Pharm. Pharmacol. 1961; 13: 492–495
   PubMed Web of Science ®Google Scholar
• Radomski J. L., Mellinger T. J. The absorption, fate and excretion in rats of the water soluble azo dyes, FD & C yellow no. 6. J. Pharmacol. Exp. Ther. 1962; 136: 259–266
   PubMed Web of Science ®Google Scholar
• Priestly B. G., O'Reilly W. J. Protein binding and the excretion of some azo dyes in rat bile. J. Pharm. Pharmacol. 1966; 18: 41–45
   PubMed Web of Science ®Google Scholar
• Iga T., Awazu S., Hanano M., Nogami H. Pharmacokinetic studies in biliary excretion. I. Comparison of the excretion behavior of azo dyes and indigo carmine. Chem. Pharm. Bull. 1970; 18: 2431–2440
   PubMedGoogle Scholar
• Bertagni P., Hirom P. C., Millburn P., Osiyemi F. O., Smith R. L., Turbert H. B., Williams R. T. Sex and species differences in the biliary excretion of tartrazine and lissamine fast yellow in the rat, guinea pig, and rabbit. The influence of sex hormones on tartrazine excretion in the rat. J. Pharm. Pharmacol. 1972; 24: 620–664
   PubMed Web of Science ®Google Scholar
• Ikeda M., Uesugi T. Studies on the biliary excretion mechanism of drugs. I. Biochem. Pharmacol. 1973; 22: 2743–2751
   PubMed Web of Science ®Google Scholar
• Miller J. A., Bauman C. A. The carcinogenicity of certain azo dyes related to p-dimethylaminoazobenzene. Cancer Res. 1945; 5: 227–234
   Web of Science ®Google Scholar
• Mueller G. C., Miller J. A. The reductive cleavage of 4-dimethylamino azobenzene by rat liver: Reactivation of carbon dioxide-treated homogenates by riboflavin-adenine dinucleotide. J. Biol. Chem. 1950; 185: 145–154
   PubMed Web of Science ®Google Scholar
• Miller J. A., Miller E. C. The carcinogenicity of certain derivatives of p-dimethylaminoazobenzene in the rat. J. Exp. Med. 1948; 87: 139–156
   PubMed Web of Science ®Google Scholar
• Miller J. A., Miller E. C., Finger G. C. Further studies on the carcinogenicity of dyes related to 4-dimethylaminoazobenzine. The requirement for an unsubstituted 2-position. Cancer Res. 1957; 17: 387–398
   PubMed Web of Science ®Google Scholar
• Miller J. A., Miller E. C. The metabolic activation of carcinogenic aromatic amines and amides. Progr. Exp. Tumor Res. 1969; 11: 273–301
   PubMed Web of Science ®Google Scholar
• Terayama H. Aminoazocarcinogenesis–methods and biochemical problems. Methods Biochem. Res. 1967; 1: 399
   Google Scholar
• Ishidate M., Hashimoto Y. Metabolism of 4-dimethylamino-azobenzene and related compounds. II. Metabolites of 4-dimethyl-aminoazobenzene and 4-aminoazobenzene in rat urine. Chem. Pharm. Bull. 1962; 10: 125–133
   Web of Science ®Google Scholar
• Ishidate M., Tamura Z., Samejima K. Metabolism of 4-dimethyl-aminoazobenzene and related compounds. III. Metabolites of 4′-dimethylaminoazobenzene in the rat bile and influence of DAB feeding on their amounts. Chem. Pharm. Bull. 1963; 11: 1014–1021
   PubMed Web of Science ®Google Scholar
• Watanabe W., Ishidate M. Metabolism of 4-dimethylamino-azobenzene and related compounds. V. Quantitative analysis of biliary and urinary metabolites of 4-dimethylaminoazobenzene in rats. Chem. Pharm. Bull. 1976; 15: 1461–1469
   Google Scholar
• Marhold J., Rambousek V., Pipalova J., Matrka M. Oxidation of carcinogenic azo-dyes. VII. Metabolites of some 4′-substituted derivatives of dimethylaminoazobenzene in the bile of rats. Neoplasma 1969; 16: 191–194
   PubMed Web of Science ®Google Scholar
• Levine W. G., Finkelstein T. T. Bilary excretion of W.JV-dimethyl-4-aminoazobenzene (DAB) in the rat. Drug Metab. Dispos. 1978; 6: 265–272
   PubMed Web of Science ®Google Scholar
• Levine W. G. Excretion mechanisms. Biological Basis of Detoxication, J. Caldwell, W. B. Jakoby. Academic Press, New York 1983; 251–285
   Google Scholar
• Mori Y., Yamamoto T., Toyoshi K. Carcinogenic azo dyes. XI. Analysis of biliary and urinary metabolites of 3-methyl-4-(methylamino) azobenzene in rat. Chem. Pharm. Bull. 1979; 27: 379–385
   PubMed Web of Science ®Google Scholar
• Levine W. G. Induction and inhibition of the metabolism and biliary excretion of the azo dye carcinogen, N,N-dimethyl-4-aminoazobenzene in the rat. Drug Metab. Dispos. 1980; 8: 212–217
   PubMed Web of Science ®Google Scholar
• Levine W. G., Lu A. Y. H. Role of isozymes of cytochrome P-450 in the metabolism of N,N-dimethyl-4-aminoazobenzene in the rat. Drug Metab. Dispos. 1982; 10: 102–109
   PubMed Web of Science ®Google Scholar
• Levine W. G., Finkelstein T. T. A role for liver glutathione in the hepatobiliary fate of N,N-dimethyl-4-aminoazobenzene. J. Pharmacol. Exp. Then 1979; 203: 399–405
   Google Scholar
• Levine W. G. Glutathione and hepatic mixed-function oxidase activity. Drug Metab. Rev. 1983; 14: 909–930
   PubMed Web of Science ®Google Scholar
• Levine W. G., Lee S. B. Effect of glutathione on the metabolism of N,N-dimethyl-4-aminoazobenzene by rat liver microsomes. Drug Metab. Dispos. 1983; 11: 239–242
   PubMed Web of Science ®Google Scholar
• Levine W. G. Glutathione, lipid peroxidation and regulation of cytochrome P-450 activity. Life Sci 1982; 31: 779–784
   PubMed Web of Science ®Google Scholar
• Kamataki T, Kitagawa H. Effects of lipid peroxidation on activities of drug-metabolizing enzymes in liver microsomes of rats. Biochem. Pharmacol. 1973; 22: 3199–3207
   PubMed Web of Science ®Google Scholar
• Miles R. R., Wright J. R., Bowman L., Colby H. D. Inhibition of hepatic microsomal lipid peroxidation by drug substrate without drug metabolism. Biochem. Pharmacol. 1980; 29: 565–570
   PubMed Web of Science ®Google Scholar
• Lindstrom T D., Aust S. D. Studies on cytochrome P-450-dependent lipid hydroperoxide reduction. Arch. Biochem. Biophys. 1984; 233: 80–87
   PubMed Web of Science ®Google Scholar
• Coles B., Srai S. K. S., Ketterer B., Waynforth B., Kadlubar F. F. Identification of 4′-sulfonyloxy-N-glutathion-S-methylene)-4-aminoazobenzene, a compound conjugated with both sulphate and glutathione, which is a major biliary metabolite of N,N-dimethyl-4-aminoazobenzene. Chem.-Biol. Interact. 1983; 43: 123–129
   PubMed Web of Science ®Google Scholar
• Coles B., Srai S. K. S., Waynforth H. B., Ketterer B. The major role of glutathione in the metabolism and excretion of N,N-dimethyl-4-aminoazobenzene in the rat. Chem.-Biol. Interact. 1983; 47: 307–323
   PubMed Web of Science ®Google Scholar
• Neish W. J. P., Rylett A. Azo dyes and rat liver glutathione. Biochem. Pharmacol. 1963; 12: 893–903
   PubMed Web of Science ®Google Scholar
• Neish W. J. P. Significance of bound dye and glutathione for amino-azo dye hepatocarcinogenesis. Chem.-Biol. Interact. 1971; 3: 109–116
   PubMed Web of Science ®Google Scholar
• Kosower N. S., Kosower E. M. The glutathione status of cells. Int. Rev. Cytol. 1978; 54: 109–160
   PubMedGoogle Scholar
• Sasame H. A., Boyd M. R. Paradoxical effects of cobaltous chloride and salts of other divalent metals on tissue levels of reduced glutathione and microsomal mixed-function oxidase components. J. Pharmacol. Exp. Ther. 1978; 205: 718–724
   PubMed Web of Science ®Google Scholar
• Terayama H. Aminoazo dye amine-N-oxide as a possible intermediate metabolite preceding N-demethylation and ortho-hydroxylation, as well as azo dye-protein binding. Gann 1963; 54: 195–204
   PubMedGoogle Scholar
• Terayama H., Orii H. Dye-protein binding in the animals administered with 4-dimethylaminoazobenzene amine-N-oxide and the toxicology of 4-dimethylaminoazobenzene-N-oxide. Gann 1963; 54: 455–464
   PubMedGoogle Scholar
• Cramer J. W., Miller J. A., Miller E. C. N-hydroxylation: A new metabolic reaction observed in rats with the carcinogen 2-acetyl-aminofluorene. J. Biol. Chem. 1960; 235: 885–888
   PubMed Web of Science ®Google Scholar
• Kadlubar F. F., Miller J. A., Miller E. C. Microsomal N-oxidation of the hepatocarcinogen N-methyl-4-aminoazobenzene and the reactivity of N-hydroxy-N-methyl-4-aminoazobenzene. Cancer Res. 1976; 36: 1196–1206
   PubMed Web of Science ®Google Scholar
• Miller E. C. Some current perspectives on chemical carcinogenesis in humans and experimental animals. Cancer Res. 1978; 38: 1479–1496
   PubMed Web of Science ®Google Scholar
• Kimura T., Kodama M., Nagata C. A correlation of the rate of N-hydroxylation of aminoazo dyes with their carcinogenic activity in the rat. Carcinogenesis 1982; 3: 1393–1396
   PubMed Web of Science ®Google Scholar
• Kimura T., Kodama M., Nagata C. N-hydroxylation enzymes of carcinogenic aminoazo dyes: Possible involvement of cytochrome P-448. Gann 1982; 73: 55–62
   PubMedGoogle Scholar
• Kimura T., Kodama M., Nagata C. The role of cytochrome P-450 and flavin-containing monooxygenase in the N-hydroxylation of N-methyl-4-aminoazobenzene in rat liver: Analysis with purified enzymes and antibodies. Gann 1984; 75: 895–904
   PubMedGoogle Scholar
• Kimura T., Kodama M., Nagata C. Nitroxide radicals generated from carcinogenic aminoazodyes during their metabolism in vivo and in enzymatic syste, in vitro. Biochem. Pharmacol. 1979; 28: 557–560
   PubMed Web of Science ®Google Scholar
• Nagata C., Kodama M., Kumura T., Nakayama T. Mechanism of metabolic activation of carcinogenic aromatic amines. Gann Monograph on Cancer Research 1985; 30: 93–110
   Google Scholar
• Sisley P., Porcher C. Du sort des matieres colorantes dans Forganisme animal. Comptes. Rend. Acad. Sci. 1911; 152: 1062–1065
   Google Scholar
• Fuller A. T. Is p-aminoazobenzenesulfonamide the active agent in prontosil therapy?. Lancet 1937; i: 194–198
   Google Scholar
• Elson L. A., Warren F. L. The metabolism of azo compounds. I. Azobenzene. Biochem. J. 1944; 38: 217–220
   PubMedGoogle Scholar
• Stevenson E. S., Dobriner K., Rhoads C. P. The metabolism of 4-dimethylaminoazobenzene in rats. Cancer Res. 1942; 2: 160–167
   Google Scholar
• Trefouel J., Trefouel J., Nitti F., Bovet D. Activite du p-aminophenylsulfamide sur les infections streptococciques. Experi-mentales de la souris et due lapin. Comptes. Rend. Seanc. Soc. Biol. 1935; 120: 756–762
   Google Scholar
• Salant W., Bengis R. Physiological and pharmacological studies on coal tar colors. I. Experiments with fat-soluble dyes. J. Biol. Chem. 1916; 27: 403–427
   Google Scholar
• Smith J. N., Williams R. T. Studies on detoxication. 36. A note on the glucuronides of benzeneazophenol and benzenazoresorcinol. Biochem. J. 1951; 48: 546–551
   PubMed Web of Science ®Google Scholar
• Mueller G. C., Miller J. A. The reductive cleavage of 4-dimethylaminoazobenzene by rat liver: The intracellular distribution of the enzyme system and its requirement for triphosphopyridine nucleotides. J Biol. Chem. 1949; 180: 1125–1136
   PubMed Web of Science ®Google Scholar
• Fouts J. R., Kamm J. J., Brodie B. B. Enzymatic reduction of prontosil and other azo dyes. J. Pharmacol. Exp. Ther. 1957; 120: 291–300
   PubMed Web of Science ®Google Scholar
• Hernandez P. H., Gillette J. R., Mazel P. Studies on the mechanism of mammalian hepatic azoreductase. I. Azoreductase activity of reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase. Biochem. Pharmacol. 1967; 16: 1859–1875
   PubMed Web of Science ®Google Scholar
• Hernandez P. H., Mazel P., Gillette J. R. Studies on the mechanism of action of mammalian hepatic azoreductase. II. The effect of phenobarbital and 3-methylcholanthrene on carbon monoxide sensitive and insensitive azoreductase activities. Biochem. Pharmacol. 1967; 16: 1877–1888
   PubMed Web of Science ®Google Scholar
• Juchau M. R., Krasner J., Yaffe S. J. Studies on reduction of azolinkages in human placental homogenates. Biochem. Pharmacol. 1968; 17: 1969–1979
   PubMed Web of Science ®Google Scholar
• Bray H. G., Clowes R. C., Thorpe W. V. The metabolism of azobenzene and p-hydroxyazobenzene in the rabbit. Biochem. J. 1951; 49, lxv
   Web of Science ®Google Scholar
• Fujita S., Peisach J. Liver microsomal cytochromes P-450 and azoreductase activity. J. Biol. Chem. 1978; 253: 4512–4513
   PubMed Web of Science ®Google Scholar
• Fujita S., Okada Y., Peisach J. Inhibition of azoreductase activity by antibodies against cytochromes P-450 and P-448. Biochem. Bio-phys. Res. Commun. 1981; 102: 492–498
   PubMed Web of Science ®Google Scholar
• Fujita S., Peisach J. The stimulation of microsomal azoreduction by flavins. Biochim. Biophys. Acta 1982; 719: 178–189
   PubMed Web of Science ®Google Scholar
• Mallett A. K., King L. J., Walker R. Solubilization, purification and reconstitution of hepatic microsomal azoreductase activity. Biochem. Pharmacol. 1985; 34: 337–342
   PubMed Web of Science ®Google Scholar
• Peterson F. J., Holtzman J. L., Crankshaw D., Mason R. P. Two sites of azoreduction in the monooxygenase system. Mol. Pharmacol. 1988; 34: 597–603
   PubMed Web of Science ®Google Scholar
• Elliott B. M. Azoreductase activity of Sprague Dawley and Wistar-derived rats towards both carcinogenic and noncarcinogenic analogues of 4-dimethylaminophenylazobenzene (DAB). Carcinogenesis 1984; 5: 1051–1055
   PubMed Web of Science ®Google Scholar
• Levine W. G. Studies on microsomal azoreduction. N,N-dimethyl-4-aminoazobenzene (DAB) and its derivatives. Biochem. Pharmacol. 1985; 34: 3259–3264
   PubMed Web of Science ®Google Scholar
• Raza H., Levine W. G. Azo reduction of N, N-dimethyl-4-aminoazobenzene (DAB) by rat liver microsomes. Selective induction by clofibrate. Drug Me tab. Dispos. 1986; 14: 19–24
   PubMed Web of Science ®Google Scholar
• De-Araujo P. S., De-Andrade-Silva E., Raw I. Effect of drugs and hormones on rat liver dimethylaminoazobenzene reductase activity. Braz. J. Med. Biol. Res 1982; 15: 17–28
   PubMed Web of Science ®Google Scholar
• Autrop H., Warwick G. P. Some characteristics of two azoreductase systems in rat liver. Relevance to the activity of 2-[4′-di(2″-bromopropyl)-aminophenylazo] benzoic acid (CB10–252.), a compound possessing cytotoxic activity. Chem.-Biol. Interact. 1975; 11: 329–342
   PubMed Web of Science ®Google Scholar
• Raza H., Levine W. G. Effect of hypolipidemic drugs on the metabolism of lauric acid and dimethylaminoazobenzene by rat liver microsomes. Biochem. Pharmacol. 1987; 36: 774
   PubMed Web of Science ®Google Scholar
• Gibson G. G., Orton T. C., Tamburini P. P. Cytochrome P-450 induction by clofibrate. Purification and properties of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid). Biochem. J. 1982; 203: 161–168
   PubMed Web of Science ®Google Scholar
• Tamburini P. P., Masson H. A., Bains S. K., Makowski R. J., Morris B., Gibson G. G. Multiple forms of hepatic cytochrome P-450. Purification, characterization and comparison of a novel clofibrate-induced isozyme with other major forms of a cytochrome P-450. Eur. J. Biochem. 1984; 139: 235–246
   PubMedGoogle Scholar
• Orton T. C., Parker G. L. The effect of hypolipidemic agents on the hepatic microsomal drug metabolizing enzyme system of the rat. Induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid. Drug Metab. Dispos. 1982; 10: 110–115
   PubMed Web of Science ®Google Scholar
• Levine W. G., Raza H. Mechanism of azoreduction of dimethylaminoazobenzene by rat liver NADPH-cytochrome P-450 reductase and partially purified cytochrome P-450. Oxygen and carbon monoxide sensitivity and simulation by FAD and FMN. Drug Metab. Dispos. 1988; 16: 441–448
   PubMed Web of Science ®Google Scholar
• Reich N. O., Ortiz P., Montellano de. Dissociation of increased lauric acid ω-hydroxylase activity from the antihypolipidemic action of clofibrate. Biochem. Pharmacol. 1986; 35: 1227–1233
   PubMed Web of Science ®Google Scholar
• Zbaida S., Stoddart A. M., Levine W. G. Studies on the mechanism of reduction of azo dye carcinogens by rat liver microsomal cytochrome P-450. Chem.-Biol. Interact. 1989; 69: 61–71
   PubMed Web of Science ®Google Scholar
• Zbaida S., Levine W. G. Characteristics of two classes of azo dye reductase activity associated with rat liver microsomal cytochrome P-450. Biochem. Pharmacol. 1990; 40: 2415–2423
   PubMed Web of Science ®Google Scholar
• Zbaida S., Levine W. G. Sensitivity of azo dye reduction to carbon monoxide and oxygen. A probe for two different microsomal reduction pathways. FASEB J. 1990; 4: A739
   Google Scholar
• Mason R. P., Peterson F. J., Holtzman J. L. Inhibition of azore-ductase by oxygen. The role of the azo anion free radical metabolite in the reduction of oxygen to superoxide. Mol. Pharmacol. 1978; 4: 665–671
   Google Scholar
• Zbaida S., Levine W. G. A novel application of cyclic voltame-try for direct investigation of metabolic intermediates in microsomal azoreduction. Chem. Res. Toxicol. 1991; 4: 82–88
   PubMed Web of Science ®Google Scholar
• Aylward G. H., Garnett J. L., Sharp J. H. Alternating and direct current polarography of azobenzene in indifferent electrolyte in dim-ethylformamide. Anal. Chem. 1967; 39: 457–460
   Web of Science ®Google Scholar
• Jannakoudakis D., Kokkinidis G., Mavridis P. G. A contribution of the polarographic reduction study of azobenzene compounds in methanol in the presence of hydrogen chloride. J. Chim. Phys. Phys.-Chim. Biol 1976; 73: 872–877
   Google Scholar
• Boto K. G., Thomas F. G. The polarography of some substituted azobenzenes in acetonitrile. V. The effects of weak proton donors. Aust. J. Chem. 1973; 26: 2417–2423
   Web of Science ®Google Scholar
• Iyanagi T., Makino N., Mason H. S. Redox properties of the reduced nicotinamide adenine dinucleotide phosphate–cytochrome P-450 and reduced nicotinamide adenine dinucleotide-cytochrome bs reductase. Biochemistry 1974; 13: 1701–1710
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Oxidation-reduction properties of rat liver cytochrome P-450 and NADPH-cytochrome P-450 reductase related to catalysis in reconstituted systems. Biochemistry 1983; 22: 2811–2820
   PubMed Web of Science ®Google Scholar
• Gunegerich F. P., Ballou D. P., Coon M. J. Purified liver microsomal cytochrome P-450. Electron-accepting properties and oxidation-reduction potential. J. Biol. Chem. 1975; 250: 7405–7414
   PubMed Web of Science ®Google Scholar
• Sligar S. G., Cinti D. L., Schenkman J. B. Spin state control of the hepatic cytochrome P-450 redox potential. Biochem. Biophys. Res. Commun. 1979; 90: 925–932
   PubMed Web of Science ®Google Scholar
• Meigs R. P., Ryan K. J. Enzymic aromatization of steroids. Effects of oxygen and carbon monoxide on the intermediate steps in estrogen biosynthesis. J. Biol. Chem. 1971; 246: 83–87
   PubMed Web of Science ®Google Scholar
• Thompson E. A., Jr., Siiteri P. K. The involvement of human placental microsomal cytochrome P-450 in aromatization. J. Biol. Chem. 1974; 249: 5373–5378
   PubMed Web of Science ®Google Scholar
• Zacharia P. K., Juchau M. Interactions of steroids with human placental cytochrome P-450 in the presence of carbon monoxide. Life Sci. 1975; 16: 1689–1692
   PubMed Web of Science ®Google Scholar
• Juchau M., Zacharia P. K. Displacement of carbon monoxide from placental cytochrome P-450 by steroids: Antagonistic effects of androstenedione and 19-norandrostenedione. Biochem. Biophys. Res. Commun. 1975; 65: 1026–1032
   PubMed Web of Science ®Google Scholar
• Kellis J. T., Jr., Vickery L. E. The active site of aromatase cytochrome P-450. Differential effects of cyanide provide evidence for proximity of heme-iron and carbon-19 in the enzyme-substrate complex. J. Biol. Chem. 1987; 262: 8840–8844
   PubMed Web of Science ®Google Scholar
• Huang M. T., Miwa G. T., Cronheim N., Lu A. Y. H. Rat liver cytosolic azoreductase. Electron transport properties and the mechanism of dicumarol inhibition of the purified enzyme. J. Biol. Chem. 1979; 254: 11223–11227
   PubMed Web of Science ®Google Scholar
• DeLong M. J., Prochaska H. J., Talalay P. Induction of NAD(P)H: quinone reductase in murine hepatoma cells by phenolic antioxidants, azo dyes, and other chemoprotectors: A model system for the study of anticarcinogens. Proc. Natl. Acad. Sci. USA 1986; 83: 787–791
   PubMed Web of Science ®Google Scholar
• Talalay P., Benson A. M. Elevation of quinone reductase activity by anticarcinogenic antioxidants. Adv. Enzyme Reg. 1982; 20: 287–300
   PubMedGoogle Scholar
• Lind C., Hochstein P., Ernster L. DT–diaphorase as a quinone reductase: A cellular device against semiquinone and superoxide radical formation. Arch. Biochem. Biophys. 1982; 216: 178–185
   PubMed Web of Science ®Google Scholar
• Roy D., Liehr J. G. Temporary decrease in renal quinone reductase activity induced by chronic administration of estradiol to male Syrian hamsters. J. Biol. Chem. 1988; 263: 3646–3651
   PubMed Web of Science ®Google Scholar
• Kitamura S., Tatsumi K. Azoreductase activity of liver aldehyde oxidase. Chem. Pharm. Bull. 1983; 31: 3334–3377
   PubMed Web of Science ®Google Scholar
• Stoddart A., Levine W. G. Reductive metabolism of azo dyes by rabbit liver aldehyde oxidase. FASEB J. 1991; 5: A843
   Web of Science ®Google Scholar
• Sugihara K., Tatsumi K. Participation of liver aldehyde oxidase in reductive metabolism of hydroxamic acids to amides. Arch. Biochem. Biophys. 1986; 247: 289–293
   PubMed Web of Science ®Google Scholar
• Tatsumi K., Kitamura S., Yamada H. Involvement of liver aldehyde oxidase in sulfoxide reduction. Chem. Pharm. Bull. 1982; 30: 4585–4588
   PubMed Web of Science ®Google Scholar
• Tatsumi K., Yamada H., Kitamura S. Reductive metabolism of JV-nitrosodiphenylamine to the corresponding hydrazine derivative. Arch. Biochem. Biophys. 1983; 226: 174–181
   PubMed Web of Science ®Google Scholar
• Kitamura S., Tatsumi K. Involvement of liver aldehyde oxidase in the reduction of nicotinamide N-oxide. Biochem. Biophys. Res. Commun. 1984; 120: 602–606
   PubMed Web of Science ®Google Scholar
• Beedham C. Molybdenum hydroxylases as drug-metabolizing enzymes. Drug Metab. Rev. 1985; 16: 119–156
   PubMed Web of Science ®Google Scholar
• Beedham C. Molybdenum hydroxylases: biological distribution and substrate-inhibitor specificity. Prog. Med. Chem. 1987; 24: 85–127
   PubMedGoogle Scholar
• Kemp M. C., Kuonen D. R., Sutton A., Roberts P. J. Rat brain NADPH-dependent diaphorase. A possible relationship to cytochrome P-450 reductase. Biochem. Pharmacol. 1988; 37: 3063–3070
   PubMed Web of Science ®Google Scholar
• Walker R. The metabolism of azo compounds, a review of the literature. FoodCosmet. Toxicol. 1970; 8: 659–676
   PubMedGoogle Scholar
• Rowland. Factors affecting metabolic activity of the intestinal microflora. Drug Metab. Rev. 1988; 19: 243–261
   PubMed Web of Science ®Google Scholar
• Jones R., Ryan A. J., Wright S. E. The metabolism and excretion of tartrazine in the rat, rabbit and man. Food Cosmet. Toxicol. 1964; 2: 447–452
   PubMedGoogle Scholar
• Gingell R., Walker R. Mechanisms of azo reduction by Streptococcus faecalis. II. The role of soluble flavins. Xenobiotica 1971; 1: 231–239
   PubMedGoogle Scholar
• Dubin P., Wright K. L. Reduction of azo food dyes in cultures of Proteus vulgaris. Xenobiotica 1975; 5: 563–571
   PubMed Web of Science ®Google Scholar
• Hartman C. P., Fluk G. E., Andrews A. W. Azo reduction of trypan blue to a known carcinogen by a cell-free extract of a human intestinal anaerobe. Mutat. Res. 1978; 58: 125–132
   PubMed Web of Science ®Google Scholar
• Chung K.-T., Fulk G. E., Egan M. Reduction of azo dyes by intestinal anaerobes. Appl. Environ. Microbiol. 1978; 35: 558–562
   PubMed Web of Science ®Google Scholar
• Zimmerman T., Kulla H. G., Leisinger T. Properties of purified Orange II azoreductase, the enzyme initiating azo dye degradation by Pseudomonas KF46. Eur. J. Biochem. 1982; 129: 197–203
   PubMedGoogle Scholar
• Zimmerman T., Gasser F., Kulla H. G., Leisinger T. Comparison of two bacterial azoreductases acquired during adaptation to growth on azo dyes. Arch. Microbiol. 1984; 138: 37–43
   PubMed Web of Science ®Google Scholar
• Kulla H. G. Aerobic bacterial degradation of azo dyes. Microbial Degradation of Xenobiotics and Recalcitrant Compounds, T. Leisinger, A. M. Cook, J. Neusch, R. Hutter. Academic Press, New York 1981; 387–399
   Google Scholar
• Horitsu H., Takada M., Idaka E., Tomoyeda M., Ogawa T. Degradation of p-aminoazobenzene by Bacillus subtilis. Eur. J. Appl. Microbiol. 1977; 4: 217–224
   Web of Science ®Google Scholar
• Idaka E., Ogawa T., Horitsu H., Tomoyeda M. Degradation of azo compounds by Aeromonas hydrophilia var. 24B. J. Soc. Dyers Colourists March, 1978; 91–94
   Google Scholar
• Wuhrmann K. K, Mechsner I., Kappeler T. L. Investigation on rate-determining factors in the microbial reduction of azo dyes. Eur. J. Appl. Microbiol. Biotechnol. 1980; 9: 325–338
   Google Scholar
• Nony C. R., Bowman M. C., Cairns T., Lowry L. K., Tolos L. P. Metabolism studies of an azo dye and pigment in the hamster based on analysis of the urine for potentially carcinogenic aromatic amine metabolites. J. Anal. Toxicol. 1980; 4: 132–140
   PubMed Web of Science ®Google Scholar
• Lynn R. K., Donielson D. W., Ilias A. M., Kennish J. M., Wong K., Matthews H. B. Metabolism of bisazophenyl dyes derived from benzidine, 3,3′-dimethylbenzidine or 3,3′dimothoxy-benzidine to carcinogenic aromatic amines in the dog and rat. J. Toxicol. Appl. Pharmacol. 1980; 56: 248–258
   PubMed Web of Science ®Google Scholar
• Cerniglia C. E., Freeman J. P., Franklin W., Pack L. D. Metabolism of azo dyes derived from benzidine, 3,3′-dimethylbenzidine, and 3,3′-dimethoxybenzidine to potentially carcinogenic aromatic amines by intestinal bacteria. Carcinogenesis 1982; 3: 1255–1260
   PubMed Web of Science ®Google Scholar
• Nony C. R., Bowman M. C. Trace analysis of potentially carcinogenic metabolites of an azo dye and pigment in hamster and human urine as determined by two chromatographic procedures. J. Chro-matogr. Sci. 1980; 18: 64–74
   PubMed Web of Science ®Google Scholar
• Bos R. P., Groenen M. A. M., Theuws J. L. G., Leydek-kers C. H. -M., Henderson P. Th. Metabolism of benzidine-based dyes and the appearance of mutagen metabolites in urine of rats after oral or intraperitoneal administration. Toxicology 1984; 31: 271–283
   PubMed Web of Science ®Google Scholar
• Bos R. P., Van Der Kruken W., Seimjsters L., Koopman J. P., deJonge H. R., Theuws J. L. G., Henderson P. Th. Internal exposure of rats to benzidine derived from orally administered benzidine-based dyes after intestinal azo reduction. Toxicology 1986; 40: 207–213
   PubMed Web of Science ®Google Scholar
• Manning B. W., Cerniglia C. E., Federle T. W. Metabolism of the benzidine-based azo dye Direct Black 38 by human intestinal mi-crobiota. Appl. Environ. Microbiol. 1985; 50: 10–15
   PubMed Web of Science ®Google Scholar
• Beland F. A., Kadlubar F. F. Formation and persistance of arylamine DNA adducts in vivo. Environ. Health Perspect. 1985; 62: 19–30
   PubMed Web of Science ®Google Scholar
• Kennelly J. C., Shaw A., Martin C. D. Reduction to benzidine is not necessary for the covalent binding of a benzidine azodye to rat liver DNA. Toxicology 1984; 32: 315–324
   PubMed Web of Science ®Google Scholar
• Urushigawa Y., Yonezawa Y. Chemico-biological interactions in biological purification systems. II. Biodegradation of azocompounds by activated sludge. Bull. Environ. Contam. Toxicol. 1977; 17: 214–218
   PubMed Web of Science ®Google Scholar
• Meyer U. Biodegradation of synthetic organic colorants. Microbial Degradation of Xenobiotics and Recalcitrant Compounds, T. Leisenger. Academic Press, New York 1982; 371–385
   Google Scholar
• Miller J. A., Miller E. C. The carcinogenic aminoazo dyes. Adv. Cancer Res. 1953; 1: 339–396
   PubMed Web of Science ®Google Scholar
• Miller J. A., Miller E. C. Some historical aspects of N-aryl carcinogens and their metabolic activation. Environ. Health Perspect. 1983; 49: 3–12
   PubMed Web of Science ®Google Scholar
• Rehn L. Blasengeschwülste bei Fuchsin-Arbeitern. Arch. Klin. Chir. 1895; 50: 588–600
   Google Scholar
• Yoshida O. A study of the aetiology of urinary bladder tumours. Jpn. J. Urol. 1973; 64: 707–712
   PubMedGoogle Scholar
• Yoshita T. Über die serienweise Verfolgung der Veränderungen der Leber der experimentellen Hepatomerzeugung durch o-aminoazo-toluol. Trans. Jpn. Pathol. Soc 1933; 23: 636–638
   Google Scholar
• Kinosita R. Researches on the carcinogenesis of various chemical substances. Gann 1936; 30: 423–426
   Google Scholar
• Van Duuren B. L. Carcinogenicity of hair dye components. J. Environ. Pathol. Toxicol. 1980; 3: 237–251
   PubMed Web of Science ®Google Scholar
• Haley T. J. Benzidine revisited: A review of the literature and problems associated with the use of benzidine and its congeners. Clin. Toxicol. 1975; 1: 13–42
   Google Scholar
• Case R. A. M., Hasker M. E., McDonald D. B., Pearson J. T. Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Part I. The role of aniline, benzidine, alpha naphthylamine and beta naphthylamine. Br. J. Ind. Med. 1954; 11: 75–96
   PubMedGoogle Scholar
• Miller E. C., Miller J. A. Mechanisms of chemical carcinogenesis: nature of proximate carcinogens and interactions with macromol-ecules. Pharmacol. Rev. 1966; 18: 805–838
   PubMed Web of Science ®Google Scholar
• Miller J. A. Carcinogenesis by chemicals: An overview. Cancer Res. 1970; 30: 559–576
   PubMed Web of Science ®Google Scholar
• Miller E. C., Miller J. A. The metabolism of chemical carcinogens to reactive electrophiles and their possible mechanisms of action in carcinogenesis, chap. 16 in. Chemical Carcinogens, C. E. Searle. ACS Monograph 173, American Chemical Society, Washington, DC 1976; 737–762
   Google Scholar
• Wright A. S. The role of metabolism in chemical mutagenesis and chemical carcinogenesis. Mutat. Res. 1980; 75: 215–241
   PubMed Web of Science ®Google Scholar
• Fischer B. Die experimentelle Erzeugung atypischer Epithel-wucherungen und die Enstehung bösortiger Geshwülste. Münch. Med. Wochenschr. 1906; 53: 2041–2047
   Google Scholar
• Scott T. S. The incidence of bladder tumours in a dyestuffs factory. Br. J. Ind. Med. 1952; 9: 127–132
   PubMedGoogle Scholar
• Kansler C. J., Sugiura K., Young N. F., Halter C. R., Rhoads C. P. Partial protection of rats by riboflavin with casein against liver cancer caused by dimethylaminoazobenzene. Science 1941; 93: 308–310
   PubMedGoogle Scholar
• Rivlin R. S. Riboflavin and cancer: A review. Cancer Res. 1973; 33: 1977–1986
   PubMed Web of Science ®Google Scholar
• Williams J. R., Grantham P. H., Yamamoto R. S., Weis-burger J. H. Effect of dietary riboflavin on azo dye reductase in liver and in bacteria of cecal contents of rats. Biochem. Pharmacol. 1970; 19: 2523–2525
   PubMed Web of Science ®Google Scholar
• Declos K. B., Miller E. C., Miller J. A., Liem A. Sulfuric acid esters as major ultimate electrophilic and hepatocarcinogenic metabolites of 4-aminoazobenzene and its /V-methyl derivatives in infant male C57BL/6J x C3H/HeJ F1 (B6C3F1) mice. Carcinogenesis 1986; 7: 277–287
   PubMed Web of Science ®Google Scholar
• Delclos K. B., Tarpley W. G., Miller E. C., Miller J. A. 4-Aminoazobenzene and N,N-dimethyl-4-aminoazobenzene as equipotent carcinogens in male C57BL/6 x C3H/He F1 mice and characterization of N-(deoxyguanosin-8-yl)-4-aminoazobenzne as the major persistent hepatic DNA-bound dye in these mice. Cancer Res. 1984; 44: 2540–2550
   PubMed Web of Science ®Google Scholar
• Prival M. J., Peiper M. D., Bell S. J. Evaluation of azo food dyes for mutagenicity and inhibition of mutagenicity by methods using Salmonella typhimurium. Mutat. Res. 1988; 206: 247–259
   PubMed Web of Science ®Google Scholar
• Reid T. M., Morton K. C., Wang C. Y., King C. M. Mutagenicity of azo dyes following metabolism by different reductive/oxida-tive systems. Environ. Mutagen. 1984; 6: 705–717
   PubMedGoogle Scholar
• Miller E. C., Miller J. A. The presence and significance of bound aminoazo dyes in the livers of rats fed p-dimethylaminoazobenzene. Cancer Res. 1947; 7: 468–480
   Web of Science ®Google Scholar
• Poirier L. A., Miller J. A., Miller E. C., Sato K. W-Benzoyloxy-N-methyl-4-aminoazobenzene: Its carcinogenic activity in the rat and its reactions with proteins and nucleic acids and their constituent. in vitro. Cancer Res. 1967; 27: 1600–1613
   PubMed Web of Science ®Google Scholar
• Kadlubar F. F., Miller J. A., Miller E. C. Hepatic metabolism of yV-hydroxy-N-methyl-4-aminoazobenzene and other/V-hydroxyl arylamines. Cancer Res. 1976; 36: 2350–2359
   PubMed Web of Science ®Google Scholar
• Kadlubar F. F., Ketterer B., Flammang T. J., Christodoulides L. Formation of 3-glutathione-5-yl-N-methyl-4-aminoazobenzene and inhibition of aminoazo dye-nucleic acid binding in vitro by reaction of glutathione with metabolically-generated N-methyl-4-aminoazo-benzene-N-sulfate. Chem.-Biol. Interact. 1980; 31: 265–278
   PubMed Web of Science ®Google Scholar
• Meerman J. H. N., van Doom A. B. D., Mulder G. J. Inhibition of sulfate conjugation of N-hydroxy-2-acetylaminofluorene in isolated perfused rat liver and in the rat in vitro by pentachlorophenol and low sulfate. Cancer Res. 1980; 40: 3772–3779
   PubMed Web of Science ®Google Scholar
• Blunck J. M., Crowther C. E. Enhancement of azo dye carcinogenesis by dietary sodium sulfate. Eur. J. Cancer 1975; 11: 23–32
   PubMed Web of Science ®Google Scholar
• Degawa M., Miyairi S., Hashimoto Y. Electrophilic reactivity and mutagenicity of ring methyl derivatives of N-acyloxy-N-methyl-4-aminoazobenzene and related azo dyes. Gann 1978; 69: 367–374
   PubMedGoogle Scholar
• King C. M., Glowinski I. B. Acetylation, deacetylation and acyl transfer. Environ. Health Persp. 1983; 49: 43–50
   PubMed Web of Science ®Google Scholar
• Flammang T. J., Kadlubar F. F. Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2′-dimethyl-4-aminobiphenyl and several N-hydroxyarylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent aceytransferases. Carcinogenesis 1986; 7: 919–926
   PubMed Web of Science ®Google Scholar
• Hashimoto Y., Degawa M., Watanabe A. K., Taka M. Amino acid conjugation of N-hydroxy-4-aminoazobenzene dyes: A possible activation process of carcinogenic 4-aminoazobenzene dyes to their ultimate mutagenic or carcinogenic metabolites. Gann 1981; 72: 937–943
   PubMedGoogle Scholar
• Lindahl T. DNA repair enzymes. Ann. Rev. Biochem. 1982; 51: 61–87
   PubMed Web of Science ®Google Scholar
• Lin J. K., Miller J. A., Miller E. C. Structures of hepatic nucleic acid-bound dyes in rats given the carcinogen N-methyl-4-aminoazo-benzene. Cancer Res. 1975; 35: 844–859
   PubMed Web of Science ®Google Scholar
• Beland E A., Tullis D. L., Kadlubar F. F., Straub K. M., Evans F. E. Characterization of DNA adducts of the carcinogen N-methyl-4-aminoazobenzene in vitro and in vivo. Chem.-Biol. Interact. 1980; 31: 1–17
   PubMed Web of Science ®Google Scholar
• Tullis D. L., Straub K. M., Kadlubar F. F. A comparison of the carcinogen-DNA adducts formed in rat liver in vivo after administration of single or multiple doses of N-methyl-4-aminoazobenzene. Chem-Biol. Interact. 1981; 38: 15–27
   PubMed Web of Science ®Google Scholar
• Tullis D. L., Dooley K. L., Miller D. W., Baetcke K. P., Kadlubar F. F. Characterization and properties of the DNA adducts formed from N-methyl-4-aminoazobenzene in rats during a carcinogenic treatment regimen. Carcinogenesis 1987; 8: 577–583
   PubMed Web of Science ®Google Scholar
• Beland F. A., Beranek D. T., Dooley K. L., Heflich R. H., Kadlubar F. F. Arylamine-DNA adducts in vitro and in vivo: Their role in bacterial mutagenesis and urinary bladder carcinogenesis. Environ. Health Perspect. 1983; 49: 125–134
   PubMed Web of Science ®Google Scholar
• Tarpley W. G., Miller J. A., Miller E. C. Adducts from the reaction of N-benzoyloxy-N-methyl-4-aminoazobenzene with deoxygua-nosine or DNA in vitro and from hepatic DNA of mice treated with N-methyl- or N,N-dimethyl-4-aminoazobenzene. Cancer Res. 1980; 40: 2493–2499
   PubMed Web of Science ®Google Scholar
• Marnett L. J. Peroxyl free radicals: Potential mediators of tumor initiation and promotion. Carcinogenesis 1987; 8: 1365–1373
   PubMed Web of Science ®Google Scholar
• Nakayama T., Kimura T., Kodama M., Nagota C. Generation of hydrogen peroxide and superoxide anion from active metabolites of naphthylamines and aminoazo dyes: Its possible role in carcinogenesis. Carcinogenesis 1983; 4: 765–769
   PubMed Web of Science ®Google Scholar
• Stier A., Clauss R., Lucke A., Reitz I. Redox cycle of stable mixed nitroxides formed from carcinogenic aromatic amines. Xenobiotica 1980; 10: 661–673
   PubMed Web of Science ®Google Scholar
• Vasdev S., Tsuruta Y, O'Brien P. J. A free radical mechanism for arylamine induced carcinogenesis involved peroxides. Biochem. Pharmacol. 1982; 31: 607–608
   PubMed Web of Science ®Google Scholar
• Labuc G. E., Blunck J. M. Metabolic activation of the hepatocar-cinogen 3′-methyl-4-dimethylaminoazobenzene by a rat liver cell-free system. Biochem. Pharmacol. 1979; 28: 2367–2373
   PubMed Web of Science ®Google Scholar
• Mori Y, Niwa T., Toyoshi K., Nagai H., Koda A., Kawada K., Ojima A., Takahashi Y. Carcinogenicity of 3′-hydroxymethyl-N,N-dimethyl-4-aminoazobenzene in rat liver. Carcinogenesis 1980; 1: 533–535
   PubMed Web of Science ®Google Scholar
• Mori Y., Niwa T., Toyoshi K., Hirano K., Sigiura M. Mutagenesis in Salmonella after metabolic activation of carcinogenic azo dyes and their isomers by liver S9 from rats, mice and hamsters. Mutat. Res. 1983; 121: 95–102
   PubMed Web of Science ®Google Scholar
• Mori H., Tanaka T., Sugie S., Kumiyasu T., Iwata H., Ni-i H., Nishwaki A., Mori Y. Hepatocarcinogenic activities of hydroxyme-thyl derivatives of 4-(N,N-dimethylamino)azobenzene in ACI/N rats. J. Natl. Cancer Inst. 1987; 79: 1159–1161
   PubMed Web of Science ®Google Scholar
• Mori Y., Niwa T., Toyoshi K. Carcinogenic activities of hydroxymethyl derivatives of 4-(dimethylamino) azobenzene in the liver of rats, mice and hamsters. Exp. Pathol. 1984; 26: 15–19
   PubMedGoogle Scholar
• Mori Y., Niwa T., Toyoshi K. Participation of cytochrome P-450 in mutagenic activation of the carcinogen, 3′-hydroxymethyl-N,N-dimethyl-4-aminobenzene and its N-demethylated compounds by rat liver. Mutat. Res. 1983; 122: 13–22
   PubMed Web of Science ®Google Scholar
• Watabe T., Hiratsuka A, Ogura K., Endoh K. A reactive hydroxymethyl sulfate ester formed regioselectively from the carcinogen, 7,12-dihydroxymethylbenz[a]anthracene, by rat liver sulfotransferase. Biochem. Biophys. Res. Commun. 1985; 131: 694–699
   PubMed Web of Science ®Google Scholar
• Watabe T., Ishizuba T., Fujieda T., Hiratsuka A., Ogura K. Sulfate esters of hydroxymethyl-methyl-benz[a]anthracene. Jpn. J. Cancer Res. 1985; 76: 684–698
   PubMedGoogle Scholar
• Surh Y.-J., Lai C.-C., Miller J. A., Miller E. C. Hepatic DNA and RNA adduct formation from the carcinogen 7-hydroxymethyl-12-methyl-benz[a]anthracene and its electrophilic sulfuric acid ester metabolite in preweaning mice and rats. Biochem. Biophys. Res. Commun. 1987; 144: 576–582
   PubMed Web of Science ®Google Scholar
• Mori Y., Niwa T., Yamazaki H., Ni-i H., Toyoshi K., Hirano K., Sugiura M. Influence of microsomal and cytosolic fractions from the liver of 4 animal species and man on the mutagenicity of carcinogenic aminoazo dyes and nature of the mutagenicity-enhancing factor in the cytosol from rat liver. Chem. Pharm. Bull. 1984; 32: 3641–3650
   PubMed Web of Science ®Google Scholar
• Levine W. G., Lee S. B. Cytosolic factors that alter the metabolism of N,N-dimethyl-4-aminoazobenzene by rat liver microsomes. Biochem. Pharmacol. 1983; 32: 3137–3144
   PubMed Web of Science ®Google Scholar
• Dipple A. Model studies for azo dye carcinogens. J. Chem. Soc. Per-kin Trans. 1972; 1: 447–449
   Google Scholar
• Stiborova M., Asfaw B., Anzenbacher P., Leseticky L., Hodek P. The first identification of the benzenediazonium ion formation from a non-aminoazo dye, l-phenylazo-2-hydroxynaphthalene (Sudan I) by microsomes of rat livers. Cancer Lett. 1988; 40: 319–326
   PubMed Web of Science ®Google Scholar
• Stiborova M., Asfaw B., Arzenbacher P., Hodek P. A new way to carcinogencity of azo dyes: The benzenediazonium ion formed from a non-aminoazo dye, l-phenylazo-2-hydroxy-naphthalene (Sudan I) by microsomal enzymes binds to deoxyguanosine residues of DNA. Cancer Lett. 1988; 40: 327–333
   PubMed Web of Science ®Google Scholar
• Buttery R. G., Guadagni D. G., Garibaldi J. A. Diazonium cations as intermediates in the microbial transformaton of chloroanilines to chlorinated biphenyls, azo compounds, and triazenes. J. Agric. Food Chem. 1979; 27: 644–646
   Web of Science ®Google Scholar
• Matsumoto M., Terayama H. Studies on the mechanism of liver carcinogenesis by certin amino azo dyes. VI. Reductive cleavage of various aminoazo dyes with rat liver homogenates. Gann 1965; 56: 169–185
   PubMedGoogle Scholar
• Lambooy J. R, Koffman B. M. 4-Dimethylaminoazobenzenes: Carcinogenicities and reductive cleavage by microsomal azo reductase. Chem.-Biol. Interact 1985; 53: 107–120
   PubMed Web of Science ®Google Scholar
• Ames B. N. The detection of carcinogens as mutagens: The Salmo-nella/microsome test. In Vitro Metabolic Activation in Mutagenesis Testing, F. J. de Serre, J. R. Fouts, J. R. Bend, R. M. Philpot. Elsevier, Amsterdam 1976; 57–62
   Google Scholar
• Williams G. M. Oetection of chemical carcinogens by unscheduled DNA synthesis in rat liver primary cell cultures. Cancer Res. 1981; 37: 45–55
   Google Scholar
• Mori H., Mori Y., Sugie S., Yoshimi N., Takahashi M., Ni-i H., Yamazaki H., Toyoshi K., Williams G. M. Genotoxocity of a variety of azobenzene and aminoazobenzene compounds in the hepatocyte/DNA repair test and the Salmonella/mutagenicity test. Cancer Res. 1986; 46: 1654–1658
   PubMed Web of Science ®Google Scholar
• Kornbrust D. J., Barfknecht T. R. Comparison of 7 azo dyes and their azo reduction products in the rat and hamster hepatocyte primary culture/DNA repair assays. Mutat. Res. 1984; 136: 255–266
   PubMed Web of Science ®Google Scholar
• Ashby J., Lefevre P. A., Styles J., Charlesworth J., Paton D. Comparisons between carcinogenic potency and mutagenic potency to Salmonella in a series of derivatives of 4-dimethylaminoazobenzene (DAB). Mutat. Res. 1982; 93: 67–81
   PubMed Web of Science ®Google Scholar
• Ashby J., Lefevre P. A., Callander R. D. The possible role of azoreduction in the bacterial mutagenicity of 4-dimethylaminoazobenzene (DAB) and 2 of its analogues (6BT and 51). Mutat. Res. 1983; 116: 271–279
   PubMed Web of Science ®Google Scholar
• Ashby J., Lefevre P. A., Burlinson B., Penman M. G. An assessment of the in vivo rat hepatocyte DNA repair assay. Mutat. Res. 1985; 156: 1–18
   PubMed Web of Science ®Google Scholar
• Dashwood R. H., Combes R. D., Ashby J. The disposition and in vivo covalent binding to liver DNA of the monoazodyes 6-(p-dimethylaminophenylazo) benzothiazole (6BT) and 5-p-dimethyl-aminophenylazo)indazole (51) after administration to the rat. Carcinogenesis 1986; 7: 1029–1033
   PubMed Web of Science ®Google Scholar
• Dashwood R. H., Combes R. H., Paton R. D., Ashby J. Mutagenicity to Salmonella of four derivatives of the azo mutagen 51: Some implications for structure-activity databases and the evaluation of combinations of mutagens. Mutagenesis 1986; 1: 261–265
   PubMed Web of Science ®Google Scholar
• Prival M. J., Mitchell V. D. Analysis of a method for testing azo dyes for mutagenic activity in Salmonella typhimurium in the presence of flavin mononucleotide and hamster liver S9. Mutat. Res. 1982; 97: 103–116
   PubMed Web of Science ®Google Scholar
• Joachim F., Burrell A., Anderson J. Mutagenicity of azo dyes in the Salmonella/microsome assay using in vitro and in vivo activation. Mutat. Res. 1985; 156: 131–138
   PubMed Web of Science ®Google Scholar
• Hashimoto Y, Watanabe H. K., Degawa M. Mutagenicity of 4-aminoazobenzene, N-hydroxy-4-aminoazobenzene, 4-nitrosoazo-benzene, 4-nitroazobenzene, and their ring methoxylated derivatives in Salmonella. Gann 1981; 72: 921–929
   PubMedGoogle Scholar
• Rinde E., Troll W. Metabolic reduction of benzidine azo dyes to benzidine in the rhesus monkey. J. Natl. Cancer Inst. 1975; 55: 181–182
   PubMed Web of Science ®Google Scholar
• Tanaka K., Mii T., Marui S., Matsubara I., Igaka H. Mutagenicity of urinary metabolites of benzidine and benzidine-based azo dyes. Int. Arch. Occup. Environ. Health 1981; 49: 177–185
   Web of Science ®Google Scholar
• Tanaka K., Mii T., Marui S., Matsubara I., Igaka H. Some aspects of metabolism and mutagenicity of o-tolidine and an o-tolidine-based azo dye. Indust. Health 1982; 20: 227–235
   PubMedGoogle Scholar
• Bowman M. C., Nony C. R., Billideau S. M., Martin J. L., Thompson H. C., Jr., Lowry L. K. Metabolism of nine benzidine-congener-based azodyes in rats based on gas chromatographic assays of urine for potentially carcinogenic metabolites. J. Anal. Toxicol. 1983; 7: 55–60
   PubMed Web of Science ®Google Scholar
• Henschler D., Wild D. Mutagenic activity in rat urine after feeding with the azo dye tartrazine. Arch. Toxicol. 1985; 57: 214–215
   PubMed Web of Science ®Google Scholar
• Munzner R., Wever J. Mutagenic activity of the feces of rats following oral administration of tartrazine. Arch. Toxicol. 1987; 60: 328–330
   PubMed Web of Science ®Google Scholar
• Lazear E. J., Shaddock J. G., Barren P. R., Louie S. C. The mutagenicity of some of the proposed metabolites of direct black 38 and pigment of yellow 12 in the Salmonella typhimurium assay system. Toxicol. Lett. 1979; 4: 519–525
   Web of Science ®Google Scholar
• Cerniglia C. E., Zhuo Z., Manning B. W., Federle T. W., Heflich R. H. Mutagen activation of the benzidine-based dye Direct Black 38 by human intestinal microflora. Mutat. Res. 1986; 175: 11–16
   PubMed Web of Science ®Google Scholar
• Lin G. H. Y., Solodar W. E. Structure-activity relationship studies on the mutagenicity of some azo dyes in the Salmonella microsome assay. Mutagenesis 1988; 3: 311–315
   PubMed Web of Science ®Google Scholar
• Shahin M. M. Evaluation of the mutagenicity of azo dyes in Salmonella typhimurium: A study of structure-activity relationships. Mutagenesis 1989; 4: 115–125
   PubMed Web of Science ®Google Scholar
• Joachim F., Decad G. M. Induction of unscheduled DNA synthesis in primary rat hepatocytes by benzidine-congener-derived azo dyes in the in vitro and in vivo/in vitro assay. Mutat. Res. 1984; 136: 147–152
   PubMed Web of Science ®Google Scholar
• Igarashi S., Yonekawa H., Kawajiri K., Watanabe J., Kimura T., Kodama M., Nagata C., Tagashira Y. Participation of the microsomal electron transport system in mutagenic activation of 4-dimethylaminoazobenzene, 4-methylaminoazobenzene and their 3′-methyl-derivatives. Biochem. Biophys. Res. Commun. 1982; 106: 164–169
   PubMed Web of Science ®Google Scholar
• Soderland E. J., Dybing E., Nordenson S., Tjelta E. The role of ethyl and fluorine substitution in the 4′ position for N,N-diethyl-4-aminoazobenzene mutagenicity and azo reduction. Ada Pharmacol. Toxicol. 1980; 47: 175–182
   PubMedGoogle Scholar
• Brown J. P., Roehm G. W., Brown R. J. Mutagenicity testing of certified food colors and related azo, xanthine and triphenyl-methane dyes with the Salmonella/microsome system. Mutat. Res. 1978; 56: 249–271
   PubMed Web of Science ®Google Scholar
• Tokiwa H., Nakagawa R., Ohnishi Y. Mutagenic assay of aromatic nitro compounds with Salmonella typhimurium. Mutat. Res. 1981; 91: 321–325
   PubMed Web of Science ®Google Scholar
• Moon R. C., Itri L. M. Retinoids and cancer. The Retinoids, M. B. Sporn, A. B. Roberts, D. S. Goodman. Academic Press, New York 1984; vol. 2: 327–371
   Google Scholar
• Sporn M. B., Newton D. L. Chemoprevention of cancer with retinoids. Fed. Proc 1979; 38: 2528–2534
   PubMedGoogle Scholar
• Baird M. B., Birnbaum L. S. Inhibition of 2-aminofluorene induced mutagenesis in Salmonella typhimurium by vitamin A. J. Natl. Cancer Inst. 1979; 63: 1093–1096
   PubMed Web of Science ®Google Scholar
• Busk L., Ahlborn U. G. Retinol (vitamin A) as a modifier of 2-aminofluorene and 2-acetylaminofluorene mutagenesis in the Salmonella/microsome assay. Arch. Toxicol. 1982; 49: 169–174
   PubMed Web of Science ®Google Scholar
• Busk L., Ahlborn U. G. Retinol (vitamin A) as an inhibitor of the mutagenicity of aflatoxin B1. Toxicol. Lett. 1980; 6: 243–249
   PubMed Web of Science ®Google Scholar
• Nomi S., Matsuura T., Ueyama H., Ueda K. Effect of vitamin A compounds on the covalent binding of benzo(a)pyrene to nuclear macromolecules. J. Nutr. Sci Vitaminol. 1981; 17: 33–41
   Google Scholar
• Shoyab M. Inhibition of the binding of 7,12-dimethylbenzanthracene to DNA of murine epidermal cells in culture by vitamin A and vitamin C. Oncology 1981; 28: 187–192
   Google Scholar
• Rocchi P., Arfellini G., Capucci A., Grilli M. P., Prodi G. Effect of vitamin A palmitate on mutagenesis induced by polycyclic aromatic hydrocarbons in human cells. Carcinogenesis 1983; 4: 245–247
   PubMed Web of Science ®Google Scholar
• Victorin K., Busk L., Ahlborn U. G. Retinol (vitamin A) inhibits the mutagenicity of o-aminoazotoluene activated by liver microsomes from several species in the Ames test. Mutat. Res. 1987; 179: 41–48
   PubMed Web of Science ®Google Scholar
• Balbinder E., Stich S. N., Sharma O. K. Complex effects of retinol on the metabolic activation of 2-aminofluorene. Environ. Mutagen. 1983; 5: 665–678
   PubMedGoogle Scholar
• Busk L. Vitamin A (retinoids) as a modifier of chemical mutagenesis and carcinogenesis. Thesis, Acta Univ. Upsal., Uppsala, Sweden, No. 740
   Google Scholar